U.S. IPO Weekly Recap: IPO Calendar Heats Up As AI Chipmaker Cerebras Rejoins The Public Pipeline
Summarize this article with:
Renaissance Capital IPO Research7.44K FollowersFollow5ShareSavePlay(10min)CommentsSummaryThe IPO market heated up this past week, with five listings raising a combined $4.5 billion. The group featured two billion-dollar deals, including the year’s largest offering to date, as well as the largest US biotech IPO ever.A wave of companies joined the pipeline this week, led by AI chipmaker Cerebras (CBRS), which filed for an estimated $2 billion IPO after canceling its previous IPO attempt in October 2025.Four sizable IPOs are currently scheduled in the week ahead, and some smaller issuers may join the calendar throughout the week.As of 4/16/2026, the Renaissance IPO Index was up 5.7% year-to-date, while the S&P 500 was up 3.2%. AlexSecret/iStock via Getty Images The IPO market heated up this past week, with five listings raising a combined $4.5 billion. The group featured two billion-dollar deals, including the year’s largest offering to date, as well as the largest US biotech IPO ever. In the pipeline, CerebrasThis article was written byRenaissance Capital IPO Research7.44K FollowersFollowRenaissance Capital provides pre-IPO research to institutional investors and investment banks. The Firm manages two IPO-focused funds: The Renaissance IPO ETF (NYSE: IPO) and the Renaissance International IPO ETF (NYSE: IPOS). Individual investors can get a free overview of the IPO market on www.renaissancecapital.com, and try a free trial of our premium platform, IPO Pro (ipopro.renaissancecapital.com).
Through Renaissance Capital’s pre-IPO research service, institutional investors get an independent opinion, in-depth fundamental analysis, and customizable financial models on all IPOs.